1. Home
  2. RVPH vs KIRK Comparison

RVPH vs KIRK Comparison

Compare RVPH & KIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • KIRK
  • Stock Information
  • Founded
  • RVPH 2006
  • KIRK 1966
  • Country
  • RVPH United States
  • KIRK United States
  • Employees
  • RVPH N/A
  • KIRK N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • KIRK Diversified Commercial Services
  • Sector
  • RVPH Health Care
  • KIRK Miscellaneous
  • Exchange
  • RVPH Nasdaq
  • KIRK Nasdaq
  • Market Cap
  • RVPH 32.8M
  • KIRK 26.7M
  • IPO Year
  • RVPH N/A
  • KIRK 2002
  • Fundamental
  • Price
  • RVPH $0.38
  • KIRK $1.18
  • Analyst Decision
  • RVPH Strong Buy
  • KIRK Buy
  • Analyst Count
  • RVPH 5
  • KIRK 2
  • Target Price
  • RVPH $9.00
  • KIRK $4.50
  • AVG Volume (30 Days)
  • RVPH 2.8M
  • KIRK 232.4K
  • Earning Date
  • RVPH 08-13-2025
  • KIRK 09-04-2025
  • Dividend Yield
  • RVPH N/A
  • KIRK N/A
  • EPS Growth
  • RVPH N/A
  • KIRK N/A
  • EPS
  • RVPH N/A
  • KIRK N/A
  • Revenue
  • RVPH N/A
  • KIRK $431,111,000.00
  • Revenue This Year
  • RVPH N/A
  • KIRK N/A
  • Revenue Next Year
  • RVPH N/A
  • KIRK N/A
  • P/E Ratio
  • RVPH N/A
  • KIRK N/A
  • Revenue Growth
  • RVPH N/A
  • KIRK N/A
  • 52 Week Low
  • RVPH $0.30
  • KIRK $1.05
  • 52 Week High
  • RVPH $4.28
  • KIRK $2.50
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 31.86
  • KIRK 52.81
  • Support Level
  • RVPH $0.35
  • KIRK $1.16
  • Resistance Level
  • RVPH $0.83
  • KIRK $1.23
  • Average True Range (ATR)
  • RVPH 0.06
  • KIRK 0.05
  • MACD
  • RVPH -0.02
  • KIRK 0.01
  • Stochastic Oscillator
  • RVPH 14.45
  • KIRK 72.22

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: